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PART A: PLAGIARISM DECLARATION 
I, Ernst Lodewicus Möller, hereby declare that the work, on which this 
dissertation is based, is my original work (except where acknowledgements 
indicate otherwise) and that neither the whole work nor any part of it has been, 
is being, or is to be submitted for another degree in this or any other university. 
I empower the university to reproduce for the purpose of research either the
whole or any portion of the contents in any manner whatsoever.












PART B: FINAL ABSTRACT 
 
Patient reported outcome measures (PROMs) in breast 




Mastectomy is the mainstay of surgical treatment for women with breast cancer in South 
Africa. The increase in breast reconstruction after a mastectomy has prompted the need to 
evaluate patient reported outcome measures (PROMs) for this set of operative intervention. 
This study aimed to assess clinical and patient reported outcome measures in immediate 




A cross-sectional study was performed on all patients who underwent immediate breast 
reconstruction between January 2011 and December 2016. This consisted of a retrospective 
clinical record review of perioperative outcomes, and a quality of life analysis using the 
BREAST-Q Post-Reconstruction questionnaire. Outcome predictors were identified using 
Chi-square, Fisher exact, One-way ANOVA, Student t-tests and Kruskal Wallis analysis of 
variance. A random-effect single arm meta-analysis was performed to compare the BREAST-
Q scores with international cohorts.  
 
Results 
A total of 52 patients were included with a mean age of  43.2 (+/-9.5) years. Eighteen patients 
(34.6%) developed early complications; of these 8 (44.4%) were major.  Thirty-one patients 
(59.6%) developed late complications; of these 18 (58.1%) were major. Fifteen patients 
(28.8%) had failed reconstruction. There was a significantly higher risk of failure following a 
total mastectomy (TM) (p=0.02), tissue expander reconstruction (TE) (p<0.01) and stage 2 
breast cancer (p=0.01). Patients who underwent nipple reconstruction and immediate-delayed 
reconstruction before 12 months, reported higher well-being and satisfaction scores. 
Compared to international cohorts our BREAST-Q scores were lower but fall within the 95% 














Immediate breast reconstruction poses a high risk of complications and reconstructive failure 
especially, with TM and TE. Our BREAST-Q scores are comparable to international studies 













































PART C: PROTOCOL 
 
Patient reported outcome measures (PROMs) in breast 





  Principle Investigator:  Dr EL Möller1 
      Email: ernstmoller_10@hotmail.com 
  Co-Investigators:  A/Prof. L Cairncross2 
      Prof. E Panieri2 
      Prof. D Hudson1  
 
1Department of Plastic and Reconstructive Surgery 
2Department of General Surgery 
University of Cape Town 
 
I. INTRODUCTION 
Breast cancer is the most commonly diagnosed among cancers in South African women. With 
21,8% of all new cancers diagnosed attributable to breast cancer and a current lifetime risk of 
1:27, makes breast cancer a significant contributor to national health statistics.1 The average 
age at which breast cancer is diagnosed, shows to be younger than developed countries2, 3 and 
younger women with breast cancer in South Africa is found to have the same clinical and 
pathological features of women in developed countries, but more advanced in presentation with 
poorer outcomes.4  
 
Mastectomy with or without axillary clearance remains the mainstay of operative management 
in South Africa, but due to a younger diagnosed population, breast conserving therapy and 
breast reconstruction after mastectomy, seems a more favourable option due to aesthetics. Very 
little research exists regarding breast reconstruction in South Africa, and rates and availability 
differ from health institutions.  
 
Research in the Western Cape has shown that factors other than demographics influence the 
patient’s decision to undergo reconstruction after mastectomy.5 Primary physician and 












concerning. 6,7 Increasing breast reconstruction rates, varying between 3 to 40% in the U.S.8-11 
has ignited the need for evaluating patient reported outcome measures such as quality of life 
and patient satisfaction. 
 
The Breast-Q questionnaire jointly developed by Memorial Sloan-Kettering Cancer Center and 
the University of British Columbia has proved to be a validated and developed tool to assess 
PROMs. 12-14 It has also been widely utilized by national health systems15 and other health 
institutions not only to illustrate the favourable outcome of breast reconstruction compared to 
mastectomy alone16, but also comparing different forms of breast reconstruction at different 
intervals.17-22 
 
At Groote Schuur Hospital in the Western Cape South Africa, patients with breast cancer 
suitable for breast reconstruction are being closely selected and counselled by a combined 
breast clinic comprising of general surgeons, plastic surgeons and oncologists. Due to limited 
theatre space and time, general surgeons only perform immediate reconstructive procedures 
and patients need to comply with the following inclusion criteria: 
a. Patient expressed need for immediate breast reconstruction  
b. Early Breast Cancer (Stage 0 – 2 disease) but excluding any stage with nodal disease 
i.e. Stage I B and stages 2A (T0 N1 MO; T1 N1 M0) and 2B (T2 N1 M0). 
Immediate reconstructions after mastectomy at Groote Schuur Hospital, entails either expander 
or implant reconstruction, with expander being favoured by far.  
 
Up to date there is no data available on patient reported quality of life and postoperative 
satisfaction in South Africa. We therefore defined the dire need to conduct such a research 
project, to evaluate whether it is achievable in the government health sector of South Africa, 
and to evaluate whether our practice of immediate reconstruction is acceptable according to 
patient reported outcomes and comparable to international statistics. 
 




1. To evaluate patient reported outcome measures (HR-QOL and patient satisfaction) in 












by the Department of Surgery, Endocrine Oncologic Unit, Grootte Schuur Hospital, 




2. To conduct an audit of all breast reconstruction patients during our selected period and 
determine if there is any statistical correlation between PROMs and their demographics, 
tumour pathology, procedure of immediate reconstruction, complications of surgery 
and postoperative care. 
3. To compare our findings with international statistics and research 
4. To determine whether PROMs evaluation and research is feasible in South African 




Study population:  
All female patients who underwent immediate implant or tissue expander reconstruction after 
mastectomy during 1 January 2011 to 31 December 2016 by the Department of General 
Surgery, Endocrine Oncologic Unit, Groote Schuur Hospital. 
 
Study design: 
Cross-sectional study involving two components: 
a. Retrospective patient folder review to obtain the following data (Appendix A): 
i. Age 
ii. Presenting complaint (Pain; Lump; Nipple discharge; Skin changes) 
iii. Breast affected (Right or Left) 
iv. Mode of Diagnosis (Mammography; Ultrasound; FNA; Histology) 
v. Type of Breast Cancer (DCIS; Ductal; Lobular etc.) including BRCA ½ 
positive patients due to their high lifetime risk for breast cancer 
vi. Receptor status of Breast Cancer (ER; PR; HER-2) 
vii. Stage of Breast Cancer (TNM) 













ix. Reconstruction procedure (Expander/Implant/Autologous) and 
(Unilateral/Bilateral) 
x. Post-reconstruction therapy (Radiation; Chemotherapy; Hormonal) 
xi. Post-reconstruction complications (Early complications i.e. hematoma; 
sepsis; seroma) 
xii. Post-operative complications (Late complications i.e Contracture of 
expander or implant capsule etc.) 
xiii. Re-operate or Re-reconstruction 
 
b. Real time Completion of the Breast-Q© Postoperative Reconstruction module 
by the identified patients  
i. Patients will be contacted personally to counsel regarding the research 
project and determine if the patient is willing to form part of the research. 
All patients must complete the questionnaire at least 1 year since their 
implant based or autologous reconstruction procedure. 
ii. Means of participation is offered to the patient as follows (in English / 
Afrikaans/ Xhosa): 
• Personally completing the questionnaire at GSH on a selected date. 
Patients in need of transportation costs will be subsidized in this 
regard 
• Receiving a posted letter with consent and questionnaire to be 
completed and prepaid envelope to return to GSH. 
• Receiving an email containing the brochure, consent and 
questionnaire to complete and return to the following address 
ernstmoller10@gmail.com.  
iii. Informed consent will be obtained before completing the questionnaire.  
iv. After completion of the questionnaire (Sections 1-6 & 11-14 only) all data 
will be kept anonymously and captured on the Breast-Q© pre-configured 
Microsoft Excel© database.  
v. The pre-configured database will be electronically submitted to the QScore© 
analysis program provided by the developers of the Breast-Q© 















c. Consent to Utilize the Breast-Q© as research tool 
i. All correspondence regarding utilization of Breast-Q©, application form and 
prerequisite guidelines as explained in the Breast-Q© User Manual will be 
completed 
 
d. Interpretation of Breast-Q© scores as calculated by QScore©  
(As described in the Breast-Q© User Manual) 
i. “All Breast-Q© scores range from 0-100. The scores are computed from the 
responses to the separate questions by adding them together and converting 
the score to a scale from 0 to 100 (like conversion into a percentage). A 
higher score means high satisfaction or better health-related quality of life.”  
ii. “The clinical meaning of BREAST-Q© scores and the smallest clinically 
significant differences are not yet defined (research is ongoing). However, 
the interpretation of the clinical significance of BREAST-Q© scores is 
facilitated by the recently available data from a study of 2000 patients at 
Memorial Sloan-Kettering Cancer Center in New York (USA). The mean 
values of QL scores in the general population are indicated with an arrow 
on the printout to serve as a rough guide for the severity of the limitations 
or symptoms. A study of the subjective significance to the patients of 
changes in QL scores suggests that a mean change of 5 to 10 on the multi-
item scales is perceived as ‘a little’ change, 10 to 20 as ‘a moderate’ change 
and greater than 20 as ‘very much’ change.” 
 
IV. STATISTICAL ANALYSIS 
 
1. All data from patient folders will be captured on a Microsoft Excel© spreadsheet via a 
Google Docs© preconfigured template.  
2. All data from the questionnaires will be analyzed using the QScore program and 
captured on an additional spreadsheet  
















The protocol will be submitted to the two following ethical bodies for approval: 
1. DRC – Reviewed and Approved 
2. Human Research Ethics Committee  
Note: During the entire research, all patient information will be kept anonymous and 
confidential. Groote Schuur Folder numbers will be used as patient identifiers during data 




Possible limitations can be expected: 
1. Poor participation in questionnaire completion due to socio-economic, accessibility 
and communication factors 
2. Language barrier with English format of questionnaire 




• Department of General Surgery Research Fund for patient transportation costs 
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1. Objectives and Aims 
Objective of the Literature Review 
a. Assess the burden of breast cancer in South Africa 
b. Explore breast reconstruction research in South Africa 
c. Explore the history, forms and outcomes of breast reconstruction techniques 
d. Define and examine the need for objective patient reported outcome measures 
e. Identify a PROMs tool for example the Breast-Q and evaluate its utilization 
 
Aim of the Study 
a. To evaluate patient reported outcome measures (HRQoL and patient satisfaction) in breast 
cancer patients who received immediate breast reconstruction after mastectomy  
b. To determine if there is any statistical correlation between PROMs and their demographics, 
tumour pathology, procedure of immediate reconstruction, complications of surgery and 
postoperative care and identify predictors of QoL 
c. To compare our findings with international literature 
 
2. Literature Search Methods 
a. Pubmed, Medline, Google Scholar and PRIMO search engine via the UCT online library 
website were used to acquire the relevant articles. Only English articles were used. 
b. Search words/phrases used: 
i. Breast cancer epidemiology 
ii. South Africa  
iii. Breast reconstruction 
iv. Autologous 
v. Implant based, prosthesis based 
vi. Delayed, Immediate, Immediate-delayed 
vii. Health related quality of life questionnaire 
viii. Patient satisfaction 
ix. Breast-Q 
x. Complications, Outcomes, Predictors 
c. Related citations by search engines were used 













3. Interpretation of Literature 
 
a. Introduction and Epidemiology of Breast Cancer 
Breast cancer is the most commonly diagnosed cancer in South African women. According to 
the National Cancer Registry, breast cancer represents 21,8% of all cancers diagnosed in South 
African women, roughly 8230 cases per year, making breast cancer a significant contributor to 
national health statistics.1 The current lifetime risk for women developing breast cancer is 1:271 
and has increased from 1:39 in 1993-1995.2 This might be due to the previous segregated and 
political fragmented public healthcare system, which excluded large portions of the population 
from adequate health care and health-related record keeping.3  
 
Although the incidence of breast cancer in South Africa has risen, possibly due to 
improvements in screening, detection and reporting, there is still low breast cancer awareness 
in many provinces4. To date, there is still no official breast cancer screening and prevention 
programs in South Africa and individual health institutions mostly drive any interventions.5 
Breast self-examination (BSE) was only performed in 9.7- 24% of patients in recent studies6, 
7, which further contributes to lack of  breast cancer detection and may impact negatively on 
the accuracy of incidence data for  breast cancer in South Africa.8 
 
As a developing country, the burden of disease related to cancer in South Africa will prove to 
be significant in the coming decades. Fregene et al. estimated a more than two-thirds cancer 
incidence increase by the year 2020, with the most significant number of female cancers 
attributable to breast cancer.9 The average age at which breast cancer is diagnosed has been 
shown to be younger than developed countries10, 11, with an age-standardized incidence rate of 
33.4 per 100000 women in Southern Africa.12 Younger women with breast cancer in South 
Africa have been found to have the same clinical and pathological features of women in 
developed countries, but more advanced in presentation and poorer outcomes.13 These facts are 
concerning for a country burdened by poverty and poor economic growth as treatment 
















b. Breast Reconstruction in South Africa and Internationally 
Throughout South Africa, both in the Private and Public health sector, mastectomy with or 
without axillary clearance is the mainstay of operative management. With a younger diagnosed 
population, Breast Conserving Therapy and or Breast Reconstruction after mastectomy are 
important surgical options for patients.  
 
In South Africa, very little published research exists regarding breast reconstruction surgery. 
Reconstructive surgery rates and availability differ from institutions and provinces in South 
Africa. Nel et al. were the first to mention mastectomy as an acceptable form of operative 
management in 1985. They also concluded that 80% of their post-mastectomy patients were 
satisfied with their postoperative physical outcome and most women had no further need for 
breast reconstruction as time progressed.14 
 
A prospective study conducted by Panieri et al. in the Western Cape, identified 135 breast 
cancer patients for loco-regional surgery. Eighty-three of these patients were considered 
suitable for mastectomy with reconstruction and 51 patients (61%), declined mastectomy and 
reconstruction with reasons not relating to their age, race, employment or marital status. Only 
34 patients (24%) underwent mastectomy with breast reconstruction.15 Therefore there is a 
need for South African health institutions in investigating the factors influencing breast 
reconstruction and providing satisfactory patient-reported outcomes after breast reconstruction.  
 
Breast reconstruction after a mastectomy has become a more prominent means of operative 
management in the last two decades. Research in the U.S. has shown reconstruction rates 
increasing from 3.4% to 8.3% over a ten year period16, but variations from 13.5 to 40% in 
breast reconstruction rates are common.17-19 Studies also revealed breast reconstruction is not 
just influenced by patient factors (i.e. age, race, marital status, ethnicity etc.), but also their 
breast and plastic surgeon’s role in their treatment.20, 21 Patient factors are usually non-
modifiable22, while referring or primary treating surgeons’ lack of knowledge and ambiguity 

















c. Forms of Breast Reconstruction 
Breast reconstruction after a mastectomy has evolved over decades, with multiple advances 
and improvements in technique and technology. Breast reconstruction in the modern day can 
either be autologous or implant-based (tissue expander or permanent implant), immediate or 
delayed. 
 
i. Implant-based reconstruction 
The introduction of the silicone implant in 1963 by Cronin and Gerow, revolutionized not only 
cosmetic breast surgery but also post-mastectomy breast reconstruction.24 The procedure 
involved a delayed insertion of the implant underneath the healed mastectomy flaps. It was 
only in 1971 when Snyderman and Guthrie successfully inserted a silicone implant under the 
remaining chest wall skin following mastectomy when immediate breast reconstruction took 
flight and prevailed for the following decade.25 Even though silicone implants initiated the 
modern era of breast reconstruction, it certainly didn’t come without its problems. A patient 
with a more extensive skin deficit after mastectomy, would not benefit from this reconstruction, 
therefore requiring additional techniques and technology to be developed. 
 
Improving on these basics of silicone implants, Radovan successfully published his results with 
skin tissue expanders in 1982.26 His technique involved the gradual expansion of breast skin 
over six weeks, to accommodate a permanent silicone implant and adequately match the 
contralateral breast dome. Tissue expanders have dramatically evolved over the last two 
decades with newer generation tissue expanders being texturized, anatomical in shape, 
including tabs to secure the expander to the chest wall and integrated ports to improve the ease 
and comfortability of the expansion process. In 1984, Becker introduced a dual-chamber tissue 
expander as part of the implant-based reconstruction armamentarium.27 The expander consisted 
of an outer shell of silicone with a saline inflatable inner shell. This eliminated the need for a 
second procedure and concurrently expanded the breast gradually with adequate symmetry. 
 
The advent of the skin-sparing mastectomy (SSM) technique by Toth and Lappert in 1991 
escalated the popularity of immediate implant-based or better known as direct-to-implant (DTI) 
reconstruction tremendously.28 By preserving skin with the SSM technique, without 
influencing the oncological safety, a sufficient breast envelope is created that can accommodate 
an implant with fewer complications and improved patient health-related quality of life and 












implant reconstructions after skin-sparing or wise pattern skin-reducing mastectomies without 
the use of an acellular dermal matrix.30 Their overall major complication rate was less than 5%, 
and only two patients had local recurrences. These findings emphasize why implant-based 
reconstruction is still the most popular form of reconstruction not just in South Africa, but 
worldwide. 
 
ii. Autologous Reconstruction 
Even though various techniques on autologous breast reconstruction was published as early as 
the 19th century, the first modern day reconstruction was considered in the late 1970s when the 
pedicled latissimus dorsi (LD) myocutaneous flap was reintroduced.31,32 Even though this flap 
allowed single staged reconstruction procedures, there was the concern that the LD flap is of 
inadequate volume, thus requiring an implant underneath. To enhance the LD flap’s volume 
for reconstruction, Hokin and Silfverskiold described the extended LD flap in 1987, 
incorporating more of the subcutaneous fat overlying the LD muscle to achieve a better breast 
mound, but with a higher incidence of fat necrosis.33 Although the LD flap underwent various 
tweaks and improvements with or without an underlying implant and satisfactory results, the 
donor site morbidity, for example, large scars on the back and prolonged seromas, was 
significant.  
 
As with implant-based reconstruction, skin sparing mastectomies eliminated large skin defects 
after mastectomy which led to various autologous harvesting techniques, with fewer donor site 
morbidity. In 1979, Robbins described the vertical rectus abdominis myocutaneous flap to 
reconstruct the breast and even though there were various adaptations of the flap, the versatility 
of abdominal flaps was discovered for breast reconstruction.34 The Transverse rectus 
abdominis myocutaneous (TRAM) flap, described in 1982 by Hartrampf and colleagues, 
became a real workhorse in pedicled autologous breast reconstruction for decades to follow.35 
Its advantages included an autologous tissue reconstruction with adequate volume for 
symmetrisation leaving an acceptable scar after harvest and concurrently an abdominoplasty. 
Although early disadvantages of possible arterial and blood supply problems and abdominal 
weakness were reported, they have become negligible with Taylor’s suggestion of strategic 
delay of the pedicle two weeks before surgery and the used of mesh reconstruction for the 













Free tissue transfer for breast reconstruction has become increasingly popular in the last 2 
decades, especially for immediate reconstruction, where fresh recipient vessels can be 
dissected out for microsurgical anastomosis. Holmstrom was the first to utilize discarded 
abdominoplasty flaps for the reconstruction of a breast in 1979.38 After that, authors like 
Grotting and Arnez published a series of successful breast reconstruction using a free TRAM 
flap.39,40 Grotting et al. also concluded that the free TRAM flap had less abdominal 
complications and fewer flap necrosis due to the limited muscle harvested. Refinements in the 
free TRAM techniques surfaced which led to the muscle-sparing TRAM (MS-TRAM) being 
utilized more often, to limit further abdominal morbidity.  Even though the MS-TRAM had 
negligible abdominal donor site morbidity, Allen and Treece refined the technique even more 
by completely retaining the rectus abdominis muscle at the donor site, thereby giving birth to 
the deep inferior epigastric artery perforator (DIEP) flap.41 Other alternatives to the free TRAM 
includes the superficial inferior epigastric artery (SIEA) flap, superior gluteal artery perforator 
(S-GAP) flap and the transverse upper gracillis myocutaneous (TUG) flap.42-44 
 
iii. Implant-based and Autologous Breast Reconstruction Outcomes 
Both implant-based and autologous reconstruction after mastectomy, especially skin-sparing 
mastectomies remains safe. Whether one option is more reliable than the other, is still 
controversial and no level 1 evidence exists. For implant-based reconstruction, Mc Carthy et 
al. stratified risk factors in determining perioperative complications.45 They found that obesity, 
smoking, hypertension and age of older than 65 years, were all independent risk factors for 
complications. Smoking, obesity and hypertension were also associated with a higher risk for 
reconstructive failure. In autologous reconstruction, Greco et al. found obesity (BMI>30), to 
be the determining risk factor for infectious and non-infectious complications post-
operatively.46 Frey et al. found that more reconstructive complications occur with direct-to-
implant and autologous reconstruction compared to tissue expansion.47 On the contrary, a 
systematic review and meta-analysis by Tsoi et al. revealed that implant-based reconstruction 
has a higher risk of reconstructive failures and surgical site infections (SSI) compared to 
autologous tissue.48 More comparative studies will be required to have adequate evidence-
















d. Patient Reported Outcome Measures after breast reconstruction 
It is well known that mastectomy for breast cancer is a major psychological stress for patients49 
and that offering breast reconstruction has improved not only physical, but also emotional well-
being.50, 51 In addition, recent studies have shown that post-mastectomy breast reconstruction, 
whether implant or autologous tissue reconstruction, is oncologically safe52-54, which makes 
post-mastectomy reconstruction even more attractive. Patient reported outcome measures 
(PROMs) have therefore become an extremely valuable tool for assessing patients’ perception 
of quality of surgical care.55 
 
The patient reported outcome measures could be regarded as a patient’s perception of their 
surgical outcome.  With the increased effort of both breast and plastic surgeons to provide 
patients with adequate guidance and statistics regarding breast reconstruction, measuring 
surgical outcome, for example: complications, morbidity and mortality, is no longer 
adequate.56 More comprehensive measures are needed, which includes objective patient 
outcomes.57 
 
The Memorial Sloan-Kettering Cancer Centre evaluated 229 quality of life measurement tools. 
Of the 229, inclusion and exclusion criteria removed 220, including ad hoc, generic, education, 
oncologic and non-English questionnaires. Some of the major critics with regarding the 
excluded questionnaires were the lack of validity, reliability and responsiveness concerning 
psychometric properties. Of the remaining seven questionnaires, six had no proper 
development invalidity and development with the last questionnaire suffering from significant 
content limitations. They concluded that a breast surgery questionnaire, should not just undergo 
full development and validation, but implement measuring tools for the different types of 





















e. The Breast-Q questionnaire and its utilization 
A questionnaire, that has proven to be extensively researched, validated and developed to assist 
in the increasing demand of PRO instruments, is the BREAST-Q©. 55,58,59 The fact that the 
Breast-Q© incorporates the clinical information of a patient’s outcome, makes the Breast-Q© 
an attractive questionnaire to utilize in clinical trials and improves the communication of 
patient related issues.60  
 
Figure 1: Three-stage approach to patient-reported outcome measure development. (From: 
Cano S, Klassen A, Pusic A. The Science behind Quality-of-Life Measurement: A Primer for 
Plastic Surgeons. Plast Reconstr Surg 2009; 123: 98e-106e) 
 
The Breast-Q© is a patient reported outcome instrument, developed jointly by Memorial Sloan-
Kettering Cancer Center and the University of British Columbia. At present, there are 4 
BREAST-Q© modules (Augmentation, Reduction, Mastectomy, Reconstruction) each of 
which comprises multiple scales. A fifth module (the BREAST-Q©: Breast Conserving 
Therapy module) is currently in development for women undergoing lumpectomy with and 
without radiation for the treatment of breast cancer.  
The overall framework of the BREAST-Q© comprise the following two head domains: HR-
QOL (Health related quality of life) and patient satisfaction.  
HR-QOL consists of 3 subdomains: physical, psychosocial, and sexual well-being. Patient 
satisfaction also consists of 3 subdomains: satisfaction with breast, satisfaction with overall 














Figure 2. Breast-Q©: Conceptual Framework (From: Pusic A, Klassen A, Scott A, et al. 
Development of a new patient reported outcome measure for breast surgery: the BREAST-Q©. 
Plast Reconstr Surg 2009; 124:345–53)  
 
 
This well researched and developed conceptual framework of the Breast-Q© has made it a 
favourite research tool in recent publications.  
 
The UK’s National Mastectomy and Breast Reconstruction Audit published in 2011, has been 
the hallmark of research evaluating PROM’s utilizing the Breast-Q©. 61 150 NHS trusts and 
114 independent hospitals in England, as well as six other trusts from Wales and Scotland, 
submitted data regarding mastectomy and breast reconstruction during the period 1 January 
2008 to 31 March 2009. Although the data submission regarding PROM’s research was 
variable, more than 8000 women received a 3- and 18-months post-mastectomy questionnaire. 
There was an excellent response rate of over 80% at both time intervals. 31% of the study 
population underwent breast reconstruction, either immediate (21%) or delayed (10%).  These 
national audit results showed that the overall experience of mastectomy and breast 
reconstruction in the NHS was excellent. It also proved that breast reconstruction had a positive 
effect on the quality of life when comparing PROM’s of mastectomy alone with these of 
immediate and delayed breast reconstruction in this cohort of patients.62 
 
Eltahir et al. found the same results in the Netherlands when they compared women undergoing 












undergoing successful reconstruction, were significantly more satisfied with the appearance of 
their breasts, fared better psychosocially, sexually and physically, and had been less pain and 
fewer limitations on physical activity. They also concluded that the Breast-Q© added a large 
amount of strength to their research as a condition-specific instrument. 63 
 
Rosson et al. utilized the Breast-Q© questionnaire to evaluate the pre-operative quality of life 
before immediate, delayed or revision reconstruction. They have found a statistical difference 
in the quality of life when comparing the revision group to the immediate and delayed group. 
Therefore, illustrating the magnitude of the effect of unsatisfactory breast reconstruction on the 
psychological functioning of patients.64 
 
The Breast-Q© has also proven to be a valuable tool in assessing the post-operative quality of 
life when comparing autologous to implant/ expander-based breast reconstruction. A cross- 
sectional survey by Hu et al. evaluated 219 patients who underwent breast reconstruction 
during 1988 – 2006. Of the 110 who had implant/expander reconstruction, 92% had saline 
implants and 90% of the autologous reconstruction group were pedicle flaps. Despite the 
autologous reconstruction group having a significantly more advanced Stage of Breast Cancer, 
patient-reported satisfaction seemed to be higher in the more extended post-reconstructive 
groups (6 – 8 & 8 ≥ years). 65 (Figure 3) 
 
This finding of greater satisfaction with autologous reconstruction has been echoed in studies 
not utilizing the Breast-Q©. Clough et al. conducted two prospective studies looking at 
cosmetic outcome after five years in implant and autologous breast reconstruction using a 5-
point global scale. Patients who underwent implant reconstruction, independent of which type, 
had a decreased patient-reported outcome of 86% at two years, to 54% after 5 years. 66 
Autologous TRAM reconstructions proved to have a more acceptable patient-reported 
satisfaction rate with 96.4% at two years and 94.2% at five years. 67 The 5-point global scale is 
more straightforward than the Breast-Q© but in this instance generated similar results, 
highlighting the fact that more patient-reported outcome instruments should be researched. 















Figure 3: Cross-sectional graph of percentage of satisfaction with reconstructed breast 
appearance over time, adjusted for age, stage, radiation, unilateral or bilateral procedure, nipple 
reconstruction and symmetry procedure. (From: Hu et al. Patient-Reported Aesthetic 
Satisfaction with Breast Reconstruction during the Long-Term Survivorship Period. Past 
Reconstr Surg 2009: 124: 1-8) 
 
 
Implant-based reconstruction has been extensively evaluated employing the Breast-Q©, 
specifically assessing the impact on patient satisfaction of silicone vs saline implants.  
Macadam et al. conducted a cross-sectional study evaluating 145 responders to the Breast-Q© 
and EORTC QLQC30 questionnaires evaluating the patient satisfaction after silicon (75 
women) and saline (68 women) implants. Mean scores of silicon vs saline using the Breast-Q© 
was compared and statistical significance even after multivariate linear regression, showed 
higher satisfaction scores in 4 subscales after silicone implants. The EORTC QLQC30, on the 
other hand, has shown no statistical difference in the global health when comparing saline and 
silicone implants.68 McCarthy et al. found similar findings in their multicentre cross-sectional 
survey but has also proven as earlier mentioned66, that patients had decreased satisfaction as 
time progressed after implant reconstruction. 69  
 
Zhong et al. utilized the Breast-Q© to evaluate the quality of life post autologous breast 
reconstruction. Fifty-one women completed the Breast-Q© after DIEP and MS-TRAM flap 












reconstruction rates as early as three weeks post-operatively but has demontrated deterioration 
in abdominal donor site during the first 3 postoperative months.70 
 
Reviewing all abovementioned research utilizing the Breast-Q©, its additive value to a Breast 
Cancer Unit is unquestionable. The fact that all this research was conducted in developed 
countries with well-organized Breast Cancer Units and adequate funding brings into question 
the possible utility of PROMs like the Breast-Q© in resource constrained developing countries.  
It is further not clear what the impact of socio-economic and patient factors i.e. level of 
education, accessibility to tertiary oncologic care, income etc. might also inhibit or influence 
the evaluation of the quality of post-operative care in developing countries.  
 
4. Conclusion 
South Africa has an increased breast cancer burden which is mainly due to improved access to 
diagnostic services among other factors. With increasing numbers of mastectomies being 
performed, whether modified radical or skin sparing, there is an increasing need for adequate 
breast reconstruction modalities, both implant-based and autologous. Although units are 
performing successful breast reconstructions after mastectomy, there is no data available on 
patient reported quality of life and postoperative satisfaction in South Africa. We, therefore, 
identified the need to conduct a research project to evaluate whether PROM tools such as the 
Breast Q could be used in the public health sector in South Africa and to assess patient 
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 Table 1: Review of International Literature 
 Abbreviations: PIBR= Permanent implant breast reconstruction; TEBR= Tissue expander breast reconstruction; ABR= Autologous breast reconstruction
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Mastectomy is the mainstay of surgical treatment for women with breast cancer in South 
Africa. The increase in breast reconstruction after a mastectomy has prompted the need to 
evaluate patient reported outcome measures (PROMs) for this set of operative intervention. 
This study aimed to assess clinical and patient reported outcome measures in immediate 




A cross-sectional study was performed on all patients who underwent immediate breast 
reconstruction between January 2011 and December 2016. This consisted of a retrospective 
clinical record review of perioperative outcomes, and a quality of life analysis using the 
BREAST-Q Post-Reconstruction questionnaire. Outcome predictors were identified using 
Chi-square, Fisher exact, One-way ANOVA, Student t-tests and Kruskal Wallis analysis of 
variance. A random-effect single arm meta-analysis was performed to compare the BREAST-
Q scores with international cohorts.  
 
Results 
A total of 52 patients were included with a mean age of  43.2 (+/-9.5) years. Eighteen patients 
(34.6%) developed early complications; of these 8 (44.4%) were major.  Thirty-one patients 
(59.6%) developed late complications; of these 18 (58.1%) were major. Fifteen patients 
(28.8%) had failed reconstruction. There was a significantly higher risk of failure following a 
total mastectomy (TM) (p=0.02), tissue expander reconstruction (TE) (p<0.01) and stage 2 












reconstruction before 12 months, reported higher well-being and satisfaction scores. 
Compared to international cohorts our BREAST-Q scores were lower but fall within the 95% 
confidence interval for Sexual Well-Being and Satisfaction with Nipples and Care.  
 
Conclusion 
Immediate breast reconstruction poses a high risk of complications and reconstructive failure 
especially, with TM and TE. Our BREAST-Q scores are comparable to international studies 
and may be useful in guiding patient consent. 
 
Introduction 
Breast cancer is the most common cancer among South African women [1]. As in other 
developing countries [2, 3], South African women with breast cancer present at an earlier age 
and with more advanced disease [4]. Mastectomy, whether total, skin-sparing or nipple 
sparing, with or without axillary clearance, remains the mainstay of surgical treatment in 
South Africa. While breast reconstruction is performed in both the private health sector and 
to a lesser extent, the public health sector, there is limited published data on breast 
reconstruction after breast cancer surgery in South Africa. In 2003, Panieri et al. showed that 
factors other than demographics influence the patient’s decision to undergo reconstruction 
after mastectomy, some of these include the choice of a more straightforward procedure, 
religious reasons, old age and regarding breast appearance as unimportant [5]. Primary 
physician and surgeon’s lack of knowledge and ambiguity towards breast reconstruction have 
also been identified as important factors in patient selection for breast reconstruction [6, 7].  
 
Internationally, with increasing numbers of bilateral mastectomies, breast reconstruction 












development of tools to objectively evaluate clinical and patient reported outcome measures 
such as post-operative complications, quality of life and patient satisfaction [9, 10]. While 
many tools and questionnaires have been developed [11], the BREAST-Q questionnaire 
jointly developed by Memorial Sloan-Kettering Cancer Centre and the University of British 
Columbia has been widely utilized by national health systems and health institutions not only 
to illustrate the favourable outcome of breast reconstruction compared to mastectomy alone, 
but also comparing different forms of breast reconstruction at different intervals [12-19]. 
 
In South Africa, while access to breast reconstruction is limited, large tertiary centre breast 
units have a careful multidisciplinary team selection process to identify suitable patients. As 
surgical resources are under tremendous pressure, this selection process is critical to ensure 
the best possible use of surgical services. Quality of life (QoL) and satisfaction after breast 
reconstruction data should be part of this process, but to date, there is no published data on 
patient reported outcome measures in South Africa.  
 
Material and Methods 
Inclusion Criteria: 
A cross-sectional study was conducted consisting of a retrospective clinical record review of 
all patients (aged 18 and above) who underwent a mastectomy with immediate breast 
reconstruction between 1 January 2011 to 31 December 2016. The patients were all managed 
by a single surgical unit, based at Groote Schuur Hospital, a large teaching, tertiary referral 
hospital, in Cape Town, South Africa, serving primarily uninsured patients. All patient 
information were included in the retrospective record review and only the patients who 
completed the BREAST-Q was included in the BREAST-Q analysis. Patients also had to be 












Exclusion Criteria:  
Patients with incomplete data sets or whom rejected informed consent, were excluded from 
the study.  
 
The following data were collected: demographics, presenting complaint, mode of diagnosis, 
type (total, skin sparing or nipple sparing) and laterality of mastectomy with or without nodal 
clearance, type of reconstruction, tumour characteristics, staging of breast cancer, adjuvant 
therapy, complications, re-operations, the outcome of final reconstruction and survival. 
Complications were divided in early (<2weeks) and late complications (>2weeks), as well as 
minor (not requiring admission or surgery i.e. surgical site infection requiring antibiotics) and 
major (requiring admission or surgery, i.e. skin flap necrosis requiring debridement or 
explant of the prosthesis). Reconstructive failure included implant or expander explant 
without re-insertion or complete autologous flap necrosis/loss. 
 
The BREAST-Q Post-Reconstruction questionnaire was then administered to all patients in 
the cohort either in person or by email. The BREAST-Q Post-Reconstruction Module, 
measures health-related quality of life (HRQoL) after breast reconstruction following 
mastectomy within 6 domains: (1) psychosocial well-being, (2) physical well-being, (3) 
sexual well-being, (4) satisfaction with breasts, (5) satisfaction with outcome, and (6) 
satisfaction with care. BREAST-Q questionnaire responses were entered into a preconfigured 
Excel spreadsheet and converted to a score of 0 – 100, using Qscore which was developed 
according to the Rasch model. The higher the score, the higher the HRQoL. As a comparator 
for these scores, we reviewed ten comparable studies which reported PROMs for an implant 
or autologous breast reconstruction using the BREAST-Q Post-Reconstruction module. The 













The demographic, clinical variables and clinical outcomes were reported using mean 
(±Standard Deviation) for numerical variables and proportions for the categorical variables. 
Outcomes of Quality of Life (QoL) numerical variables were reported as mean (±Standard 
Deviation) since they were normally distributed for the different clinical characteristics. The 
group differences in categorical variables were tested using Chi-square tests, or Fisher exact 
tests when group numbers were small (expected frequency <5 in any cell) and the large 
number assumption for Chi-square tests were not met. Analysis of variance (One-way 
ANOVA) or Student t-tests (equal/unequal variance) was used for continuous, normally 
distributed variables. Kruskal Wallis analysis of variance; a non-parametric test, was used for 
variables that were not normally distributed. To test the strength of association between 
numerical variables, Pearson correlation coefficients/coefficient of determination (r/r2) were 
reported. A p-value of ≤0.05 was used as the threshold for statistical significance. To 
compare the BREAST-Q means of our study with international literature, we conducted a 
random-effect single arm meta-analysis of the mean scores. 
 
Ethics 
Approval was obtained from the Human Research Ethics Committee of the Faculty of Health 




Fifty-four patients underwent immediate breast reconstruction after mastectomy from 1 
January 2011 to 31 December 2016 (Table 1). Two patients were excluded due to lack of 












mastectomies (TM), 26 (50%) had skin-sparing mastectomies (SSM) and none had nipple 
sparing mastectomies (NSM). Thirty-three patients (63.5%) had tissue expander (TE) 
reconstruction, 15 patients (28.8%) had immediate implant reconstruction and 4 patients 
(7.7%) had autologous reconstruction.  Only 13 patients (25%) had nipple-areola 
reconstruction. The majority of patients presented with invasive ductal carcinoma (73.1%); 
77% of these were in earlier stages (Stage 0 – 2). Adjuvant treatment consisted of 
radiotherapy in 22  (42.3%),  chemotherapy in 32 (61.5%) and hormonal therapy in 30 
(57.7%) patients respectively. All Stage 3 patients received neoadjuvant chemotherapy.  
82.7% of the patients are alive free of disease, 7.7% are documented to have a recurrence and 
9.6% died. Of the 5 patients whom died, one had stage 2 and four had stage 3 disease and all 
deaths were breast cancer related.  
 
Post-Reconstruction Complications 
Eighteen patients (34.6%) developed early complications; of these 8 (44.4%) were major. 
Thirty-one patients (59.6%) presented with late complications; of these 18 (58.1%) were 
major. Of the patients with major late complications, 12/18 (66.7%) had no early 
complications, 4/18 (22.2%) had minor early complications and only 2/18 (11.1%) had early 
major complications. There was no statistical significance between the early complication 
groups for all variables. There was however a higher distribution of major early 
complications with unilateral mastectomy (87.5%), TE reconstruction (62.5%), Stage 1 breast 
cancer (37.5%) and chemotherapy (62.5%) (Table 2a). 
 
There was a statistically significant difference (p=0.03) for late complications groups when a 
unilateral mastectomy was performed. There was a higher distribution of  major late 












absence of contralateral procedure (61.1%), Stage 2 breast cancer (55.6%), Chemotherapy 
(55.6%) and Hormonal Therapy (66.7%), though these did not reach statistical significance 
(Table 2b). 
 
Final Outcome of Reconstruction (Table 2c) 
Fifteen patients (28.8%) had failed post-mastectomy breast reconstruction. Most of these 
(12/15 -80%) resulted from major late complications. The primary reason for reconstruction 
failure was wound dehiscence in 7 patients, infections in 6, cancer recurrence in 1,  and 
mechanical failure in one further case.. There was a statistically significant higher risk for 
reconstructive failure associated with TM (p=0.02), expander reconstruction (p<0.01) and 
stage 2 breast cancer (p=0.01). There was also a higher distribution of failed reconstructions 
for unilateral mastectomy (60%), nodal clearance (53.3%), the absence of contralateral 
procedure (66.7%), radiotherapy (66.7%), chemotherapy (73.3%) and hormonal therapy 
(60%). Of the patients who died, four out of five had expander reconstructions and one 
autologous reconstruction. All four expander reconstructions failed.  
 
BREAST-Q response distribution, predictors of HRQoL and meta-analysis 
Thirty-six patients completed the BREAST-Q post-reconstruction module (response rate of 
75%), excluding five cancer related deaths. Sixteen patients completed the Breast-Q via 
email and twenty patients completed it in person. The mean scores for each domain are 
depicted in Fig.1. The BREAST-Q responses correlating to the clinical variables are depicted 
in Table 3. Predictors for better Psychosocial Well-Being included nipple reconstruction 
(p=0.05) and the absence of hormonal therapy (p=0.01). Predictors for better Sexual Well-
Being included SSM (p=0.03), absence of nodal clearance (p=<0.01), nipple reconstruction 












hormonal therapy (p<0.01), and immediate-delayed breast reconstruction within 12 months 
(p=0.01). Unilateral mastectomy with prophylactic contralateral mastectomy was the only 
predictor for better Physical Well-Being (p=0.03). Predictors for higher Satisfaction with 
Breast was nipple reconstruction (p=0.04) and predictors for higher Satisfaction with 
Outcome was the absence of early complications (p=0.04)  and immediate-delayed breast 
reconstruction within 12 months (p=<0.01). 
 
Table 4 outlines the BREAST-Q scores of 11 studies, ours included, assessing implant-based 
and autologous breast reconstruction either combined or independently. Only three studies 
including ours assessed all domains of the BREAST-Q. When compared to the meta-analysis 
model, our scores are slightly lower for each domain but fall within the 95% CI for Sexual 
Well Being, Satisfaction with Nipples, Satisfaction with Information and Satisfaction with 
Office personnel (Fig. 2). 
 
Discussion 
Mastectomy, whether total, skin sparing or nipple sparing, has a major psychological impact 
on a patient’s life [20]. Breast reconstruction following mastectomy improves not only 
physical, but also emotional well-being [21]. Recent studies confirmed that post-mastectomy 
breast reconstruction, whether autologous or implant-based, is oncologically safe. This has 
led to a significant increase in breast reconstruction worldwide [22]. However, although 
breast reconstruction may improve patients’ HRQoL, outcomes are variable and major 
complications are common.    
 
With the increasing effort of both breast and plastic surgeons to provide patients with 












outcomes (complications, morbidity and mortality), is no longer adequate [11]. More 
comprehensive measures are needed, including objective patient outcome assessments [23]. 
By evaluating these PROMs, predictors of QoL can be identified and communicated to 
patients, to assist in their post-mastectomy reconstructive plan. 
 
Implant-based reconstruction with tissue expander as preferred method remains the most 
common form of breast reconstruction in the USA [24]. This finding is confirmed in our 
study with 63.5% of patients undergoing TE. Although implant-based reconstruction is 
relatively simple, with no donor site morbidity and more rapid recovery, major complications 
have been reported in up to 46% of patients [25]. In our study population, 15.7% and 36.4% 
respectively developed major early and late complications. Of concern to us was the fact that 
66.7% of patients with major late complications, had no early complications, which could be 
due to underreporting or missed early complications and needs to be addressed in our post-
operative care.  
 
Although early complications (<2 weeks) are usually indicative of possible technical 
challenges during surgery, major late complications (>2 weeks) remains the primary 
predictor of reconstructive failure as seen in our cohort. Contradictory to Roostaien et al. our 
tissue expander patients presented with more major complications compared to immediate 
implants [26]. This could be attributed to higher rates of nodal clearance, perioperative 
chemotherapy and hormonal therapy in the TM patients in our cohort. While multiple studies 
found no overall differences in complications when it came to the type of mastectomy and 
perioperative chemotherapy, our research proves otherwise [27, 28]. Regarding nodal 
clearance and perioperative hormonal therapy (Tamoxifen), our study confirms an increased 












mastectomy was the only variable which predicted an increased risk of late complications 
(p=0.03) A single other study by Jagsi et al. has shown an increased risk for infections in the 
first two years for patients undergoing unilateral mastectomy and reconstruction [31]. 
 
Complications increase morbidity throughout the reconstruction process, but the outcome of 
the final reconstruction rests on implant success or failure. In our study, fifteen patients 
(28.8%%) had failed breast reconstruction post-mastectomy of which 12 were TE and three 
immediate implants. Even though this is higher than the 20% reported by Momoh et al. [32], 
one patient had tissue expander mechanical failure and elected not to proceed further while 
another had tissue expander explant due to recurrence. The majority of our patients had 
explants due to infection or wound-related complications, which is in keeping with other 
studies [33, 34]. TE reconstruction (p<0.01), TM (p=0.02) and Stage 2 breast cancer (p=0.02) 
were statistically significant predictors for implant failure. A smaller skin envelope and 
thinner mastectomy flaps with TM may raise the risk for infectious and wound complications 
and thereby implant failure [35]. Furthermore, the fact that our cohort mortalities had a 
higher stage disease and failed reconstruction was associated only with expanders, either 
delayed, or no reconstruction should rather be offered. Worth reporting, although not 
statistically significant is the presence of perioperative radiotherapy in 66.7% of our failed 
reconstruction patients, as radiation significantly increases failure rates in implant-based 
reconstruction [36].  
 
The overall response rate for the completion of the BREAST-Q was 75% which is lower than 
other studies which reported over 80% response rates [16, 37]. This may be due to the overall 
poor clinical follow up, prohibitive transport costs for patients and difficulty making contact 












identified clear predictors for QoL after breast reconstruction. Matthews et al. determined the 
type of reconstruction as a predictor for Satisfaction with Outcome with DIEP reconstruction 
being favoured and psychological well-being a key predictor for Satisfaction with Breast 
[38]. In contrast, our study found that only nipple reconstruction increased Satisfaction with 
Breast appearance, an association which has been reported in other studies [39]. The absence 
of early complications and TE reconstruction completed within 12 months had the highest 
Satisfaction with Outcome in our research. As waiting times are exceptionally long in our 
clinical service, a correlation of satisfaction with earlier reconstruction may assist in 
motivating for earlier surgical dates.  
 
When evaluating well-being as a domain for HRQoL after breast reconstruction, Cereija-
Garea et al. provided a comprehensive study of associations with multiple variables [40]. The 
variables associated with the worst quality of life for Physical Well-Being was SSM and 
lymphedema, while immunotherapy accounted for the worst scores on Sexual and 
Psychosocial Well-Being. In our study, bilateral risk-reducing mastectomies predicted worst 
Physical Well-being scores regardless of the type of mastectomy. TM, nodal clearance, the 
absence of nipple reconstruction, later stage breast cancer, perioperative radiotherapy and 
failed reconstruction, resulted in lower Sexual Well-Being scores. Our finding of poorer 
Sexual Well-Being scores for patients who had undergone nodal clearance and perioperative 
radiotherapy coincides with other literature [40, 41]. However, hormonal therapy, which 
predicted poor Sexual and Psychosocial Well-Being in our study was found to have little 
impact on QoL by Schover et al. [42]. 
 
To date, only one meta-analysis using the BREAST-Q has been performed, comparing 












concluded that both options have high scores for satisfaction and well-being, but autologous 
breast reconstruction demonstrated significantly higher scores. As we conducted a single arm 
meta-analysis model combining both implant-based and autologous reconstruction, we 
cannot comment on the difference between them, but confirm that our model’s BREAST-Q 
scores are similar to other studies [14, 37, 40, 44-50].  
 
Limitations and Weaknesses 
The size of this cohort is a significant limitation and has impacted on the significance of 
some of the findings. This small size is due to difficult access to theatre time to perform 
larger numbers of reconstructions and also due to unobtainable and incomplete clinical 
records limiting the number of patients included. Although some patients completed the 
BREAST-Q by email and not in person, validity studies has shown no bias in the completion 
method [10]. The BREAST-Q questionnaire has not specifically been validated in our 
socioeconomic context and was not translated for this study which may have influenced the 
responses. There are also substantially more implant-based reconstructions, than autologous, 
which will skew the BREAST-Q score analysis.  
 
Conclusion 
Immediate breast reconstruction post-mastectomy, while desirable for many patients, carries a 
high risk of major complications and implant failure. Tissue expander reconstruction remains 
the mainstay of implant-based reconstruction but is associated with higher major complications 
rates and reconstructive failure especially with TM, later staged breast cancers and 
perioperative radiotherapy. This has influenced our unit’s selection criteria for immediate 
reconstruction by selecting younger patients with early stage breast cancer and without the 












and predictors of improved outcomes which can be used to guide patients in their decision 
making. Comparable BREAST-Q scores with international cohorts confirm the feasibility of 
these studies in developing countries. However further robust prospective research evaluating 
HRQoL in South African breast reconstruction patients is necessitated, especially evaluating 
autologous and implant-based reconstruction independently and in comparison with greater 
cohort numbers.   
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Tables and Figures 
Table 1. Baseline characteristics of the study population (N=52) 
Characteristic Distribution 
Age at surgery (years), mean (±SD) 43.2 (9.5) 
Presenting Complaint, n (%) 
Lump 
















Mode of Diagnosis (Imaging), n (%) 
Mammogram 
















Laterality of Mastectomy, n (%) 
Bilateral risk reducing 
Unilateral  














Axillary Nodal Clearance, n (%) 25 (48.1) 


























Nipple Reconstruction, n (%) 13 (25) 
Histological Type of Breast Cancer, n (%) 
DCIS/ LCIS/ Paget’s 
Invasive Ductal  





















Tumour Stage, n (%) 























Metastasis Stage (M0), n (%) 52 (100) 










Radiotherapy, n (%) 22 (42.3) 
Chemotherapy, n (%) 32 (61.5) 
Hormonal Therapy, n (%) 30 (57.7) 



































Outcome of Final Reconstruction, n (%) 
Failed 
Immediate 
Immediate delayed (<12 months) 














Abbreviations:  BRCA= Breast cancer gene; DCIS / LCIS= Ductal / Lobular carcinoma in situ; ER= Estrogen receptor; PR= Progesterone receptor; 












Table 2a. Distribution of early complications in study population (n=52) 
Characteristic None (n=34) Minor (n=10) Major (n=8) p-value 
Age at Surgery (years), mean (±SD) 42.3 (9) 43 (11.6) 47.4 (8.7) 0.40 
Laterality of Mastectomy, n (%) 
  Bilateral risk reducing 
  Unilateral  





























Axillary Nodal Clearance, n (%) 16 (47.1) 7 (70) 2 (25) 0.19 






















































Radiotherapy, n (%) 15 (44.1) 5 (50) 2 (25) 0.53 
Chemotherapy, n (%) 20 (58.8) 7 (70) 5 (62.5) 0.81 
Hormonal Therapy, n (%) 18 (52.9) 8 (80) 4 (50) 0.28 














Table 2b. Distribution of late complications in study population (n=52) 
Characteristic None (n=21) Minor (n=13) Major (n=18) p-value 
Age at Surgery (years), mean (±SD) 45.2 (10.2) 42.1 (8.3) 41.7 (9.5) 0.45 
Laterality of Mastectomy, n (%) 
  Bilateral risk reducing 
  Unilateral  





























Axillary Nodal Clearance, n (%) 9 (42.9) 7 (53.9) 9 (50) 0.81 






















































Radiotherapy, n (%) 7 (33.3) 7 (53.9) 8 (44.4) 0.49 
Chemotherapy, n (%) 16 (76.2) 6 (46.2) 10 (55.6) 0.18 
Hormonal Therapy, n (%) 9 (42.9) 9 (69.2) 12 (66.7) 0.20 













Table 2c. Distribution of Outcome of Final Reconstruction in study population (n=52) 
Characteristic Failed (n=15) Immediate (n=14) Immediate delay <12 
months (n=5) 
Immediate delay 
>12 months (n=18) 
p-value 
Age at Surgery (years), mean (±SD) 40.2 (10.9) 43.6 (10.1) 44.8 (4.1) 44.9 (8.8) 0.53 
Laterality of Mastectomy, n (%) 
  Bilateral risk reducing 
  Unilateral  


























































Axillary Nodal Clearance, n (%) 8 (53.3) 3 (21.4) 3 (60) 11 (61.1) 0.13 












































Radiotherapy, n (%) 10 (66.7) 3 (21.4) 2 (40) 7 (38.9) 0.10 
Chemotherapy, n (%) 11 (73.3) 5 (35.7) 4 (80) 12 (66.7) 0.57 
Hormonal Therapy, n (%) 9 (60) 6 (42.9) 2 (40) 13 (72.2) 0.32 













Table 3. Distribution of BREAST-Q outcomes and study population characteristics (N=36) 
 WBPsy WBS WBPhy SBreast SOut 
  p-value  p-value  p-value  p-value  p-value 
Age at Surgery, r2 (%) 0.4 0.72 0.04 0.89 2.3 0.37 4.4 0.22 1.0 0.58 
Laterality of Mastectomy, mean (±SD) 
  Bilateral risk reducing 
  Unilateral  
  Unilateral therapeutic and contralateral    










































































































































































































































































































































































































































Outcome of Final Reconstruction, mean (±SD) 
Failed 
Immediate 
Immediate delayed (<12 months) 





































Abbreviations: WBPsy= Psychosocial Well-Being; WBS= Sexual Well-Being; WBPhy= Physical Well-Being; SBreast= Satisfaction with Breasts; SOut= Satisfaction with Outcome 













Table 4. Review of International Literature 
*Abbreviations: PIBR= Permanent Implant Breast Reconstruction; TEBR= Tissue expander breast reconstruction; ABR=Autologous breast reconstruction 


































92 75.5 (+/- 17.9) 61.1 (+/- 22.4) 74.6 (+/- 16.3) 70.5 (+/- 17.9) 64.6 (+/- 30.3) 
78.4 (+/- 
19.1) 71 (+/- 15.1) 90.4 (+/- 15.3) 86.7 (+/-20.1) 86 (+/-19.2) 













52.1 (+/- 18.6) 
 
64.8 (+/- 20.9) 
78.7 (+/- 12.9) 
 
79.1 (+/- 15.6) 
64.2 (+/- 12.6) 
 










67.4 (+/- 18.8) 
 
80.4 (+/-13.6) 
82.4 (+/- 20.4) 
 


























73.5 (+/- 10) 
52.7 (+/- 18.5) 
 
51.7 (+/- 6.8) 
75.1 (+/- 13.4) 
 
67.5 (+/- 9.5) 
59.3 (+/- 11.8) 
 
69.1 (+/- 6.2) 
57.5 (+/- 25.6) 
 






66.8 (+/- 16.1) 
 
72.1 (+/- 16.5) 
86.9 (+/- 16.8) 
 
95.5 (+/- 7.6) 
92.9 (+/ 14.5) 
 
80.8 (+/- 20.1) 
90.1 (+/- 16.6) 
 
81.5 (+/- 18.0) 
Aguiar et 
al.[44] 2017 PIBR; TEBR 
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53 (+/- 21.2) 
 
55.4 (+/- 19.8) 
76.7 (+/- 14.5) 
 
74.9 (+/- 15.1) 
64.0 (+/- 16.8) 
 
67.8 (+/- 17.2) 














52.7 (+/- 21.1) 
 
55.5 (+/- 20.6) 
76.0 (+/- 14.6) 
 
74.9 (+/- 15.1) 
63.1 (+/- 17.4) 
 
68.6 (+/-17) 








101 75.3 (+/- 19.5) 63.4 (+/- 23.7) 70.4 (+/- 16.8) 60.8 (+/- 18.8) 71.3 (+/- 24.4) 
75.3 (+/- 









74.4 (+/- 19) 54.8 (+/- 21.4) 76.3 (+/- 14.8) 65.1 (+/- 18.1) - - - - - - 




36 70.7 (+/- 21.5) 54.1 (+/- 26.1) 68.4 (+/-17.5) 59.6 (+/-18.5) 69 (+/- 28.1) 
69.3 (+/- 
26.7) 65.9 (+/- 23.4) 85.1 (+/- 22,2) 88.7 (+/- 17.8) 88.6 (+/- 19.2 
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